Relationships between Cytokine Profiles and Signaling Pathways (IκB Kinase and p38 MAPK) in Parainfluenza Virus-Infected Lung Fibroblasts by Yoshizumi, Masakazu et al.
www.frontiersin.org  November 2010  | Volume 1  | Article 124  |  1
Original research article
published: 15 November 2010
doi: 10.3389/fmicb.2010.00124
Relationships between cytokine profiles and signaling 
pathways (IκB kinase and p38 MAPK) in parainfluenza 
virus‑infected lung fibroblasts
Masakazu Yoshizumi1,2, Hirokazu Kimura3*, Yoshimichi Okayama4*, Atsuyoshi Nishina5, Masahiro Noda6, 
Hiroyuki Tsukagoshi1, Kunihisa Kozawa1 and Masahiko Kurabayashi2
1  Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi-shi, Gunma, Japan
2  Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi-shi, Gunma, Japan
3  Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan
4  Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Science, Tokyo, Japan
5  Department of Health and Nutrition, Yamagata Prefectural Yonezawa Women’s Junior College, Yonezawa-shi, Yamagata, Japan
6  Department of Virology III, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan
Respiratory viruses such as parainfluenza virus (PIV) in individuals with certain genetic 
predispositions in early life are associated with the induction of wheezing, which can progress to 
the development of asthma. It has been suggested that aberrant production of various cytokines 
due to viral infection are associated with virus-induced asthma. However, the mechanisms of 
how respiratory viruses induce and exacerbate asthma have yet to be clarified. To examine 
cytokine responses to PIV infection, we assessed 27 cytokine levels released from PIV-infected 
human fetal lung fibroblasts. In addition, we examined relationships between these cytokine 
responses and signaling pathways (IκB kinase and p38 MAPK) in PIV-infected cells. At 24 h after 
infection, PIV-infected cells significantly released a number of cytokines, namely, proinflammatory 
cytokines [interleukins (IL)-1β, IL -6, and tumor necrosis factor-α], anti-inflammatory cytokine 
(IL -1ra), Th1 cytokines (interferon-γ, and IL -2), Th2 cytokines (IL -4, IL -5, and IL -10), granulopoiesis-
inducing cytokines (granulocyte colony-stimulating factor  and granulocyte–macrophage colony-
stimulating factor), neutrophil recruitment-inducing cytokines (IL -8 and interferon-inducible 
protein-10), and eosinophil recruitment-inducing cytokines (eotaxin and regulated on activation 
normal  T-cell expressed and secreted). PIV infection enhanced phosphorylation of both IκB and 
p38 MAPK, but not Akt, in the cells. Signaling pathway inhibitors, BMS-345541 (a specific IκB 
kinase inhibitor) and SB203580 (a specific p38 MAPK inhibitor), significantly suppressed release 
of these cytokines from PIV-infected cells.  The results indicate that PIV infection induces aberrant 
production and release of various cytokines through IκB kinase and p38 MAPK pathways in 
human lung fibroblasts. Overproduction and imbalance of these cytokines may be partially 
associated with the pathophysiology of virus-induced asthma.
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be associated with not only respiratory infections but also the 
  induction and exacerbation of asthma (virus-induced asthma) 
(Azevedo et al., 2003; Matsuse et al., 2005). However, many children 
who wheeze with viral infections during infancy will not go on to 
develop asthma, suggesting a role of virus- and/or host-specific 
factors in the pathogenesis of the disease.
Most types of cytokines may be associated with the pathophysiol-
ogy of virus-induced asthma or excessive virus-induced inflammation 
(Mallia and Johnston, 2006; Proud and Chow, 2006). In extreme cases, 
an overproduction of cytokines due to viral infection (e.g., influenza 
virus infection) may induce a cytokine storm resulting in systemic 
inflammatory response syndrome (SIRS) (Watanabe et al., 2003). 
Thus, viral infection-induced overproduction of cytokines in vivo 
might be closely associated with the pathophysiology of various 
diseases including asthma (Message and Johnston, 2004; Mallia and 
Johnston, 2006; Proud and Chow, 2006). However, cytokine profiles 
of viral infections including PIV infection remain largely unknown.
IntroductIon
Respiratory  viruses  are  responsible  for  most  acute  respiratory 
illnesses  in  humans,  including  the  common  cold,  bronchioli-
tis,  and  pneumonia  (Johnston,  2004).  These  major  pathogens 
include human parainfluenza viruses (PIV), rhinoviruses (RV), 
respiratory syncytial virus (RSV), and influenza viruses (Monto, 
2004). Respiratory infections resulting from PIV, RV, and RSV 
have also been implicated in the induction and exacerbation of 
asthma (Folkerts et al., 1998; Stein et al., 1999; Azevedo et al., 2003; 
Kotaniemi-Syrjänen et al., 2003; Martinez, 2003; Matsuse et al., 
2005; Hershenson and Johnston, 2006; Khetsuriani et al., 2007; 
Kusel et al., 2007). Most children are infected at least once with 
PIV early in life, but reinfections occur throughout life. Serologic 
surveys indicate that at least 60% of children have been infected 
with PIV3 by 2 years of age while approximately 80% have been 
infected by 4 years of age. PIV are associated with 0–12% of acute 
lower respiratory tract infections in adults. PIV infections may Frontiers in Microbiology  |  Virology    November 2010  | Volume 1  | Article 124  |  2
Yoshizumi et al.  Cytokines/signaling of parainfluenza virus infection
We measured the following 27 cytokines using an available 
kit (Cytokine assay 27-Plex Panel kit, Bio-Rad, Hercules, CA, 
USA): interleukins (IL)-1β, 1ra, 2, 4, 5, 6, 7, 8, 9, 10, 12, 13, 15, 
and 17, interferon (IFN)-γ, granulocyte colony-stimulating fac-
tor (G-CSF), granulocyte–macrophage colony-stimulating factor 
(GM-CSF), tumor necrosis factor (TNF)-α, monocyte chemoat-
tractant protein (MCP)-1, macrophage inflammatory protein 
(MIP)-1α,  1β,  interferon-inducible  protein  (IP)-10,  eotaxin, 
fibroblast growth factor (FGF) basic, platelet-derived growth fac-
tor (PDGF)-bb, regulated on activation normal T-cell expressed 
and secreted (RANTES), and vascular endothelial growth factor 
(VEGF). Assays were performed using the Bio-Plex suspension 
array system according to the manufacturer’s instructions (Bio-
Rad). Data were automatically processed and analyzed using Bio-
Plex Manager Software 5.0 with the standard curve produced 
from the recombinant cytokine standard. The sensitivity limits 
for each cytokine were set at 0.1–3 pg/ml (Okazaki et al., 2008; 
Yoshizumi et al., 2008).
MeasureMent of phosphorylatIon InhIbItIon of Iκb kInase, p38 
Mapk, and akt
The  inhibitors  BMS-345541  (4(2′-aminoethyl)ami-
no-1,8-dimethylimidazo(1,2-a)quinoxaline),  a  specific 
inhibitor  of  IκB  kinase),  SB203580  (4-(4-fluorophenyl)-2-(4-
methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole, a specific inhib-
itor of p38 MAPK), and Akt inhibitor X (10-(4-(N-diethylamino)
butyl)-2-chlorophenoxazine,  HCl)  were  purchased  from 
Calbiochem (KGaA, Darmstadt, Germany). These compounds 
were dissolved in DMSO (10 mM) and stored at −80°C until 
required. The optimal concentration of each of these specific 
inhibitors of signaling protein phosphorylation was preliminary 
examined, and 10 μM of each inhibitor was found to be suitable for 
significant inhibition of the phosphorylation of the kinases, results 
which are compatible with previous reports (MacMaster et al., 
2003; Thimmaiah et al., 2005; Zaheer et al., 2009). Phosphorylation 
of signal molecules induced by PIV was also assessed using a Bio-
Plex suspension array system.
statIstIcal analysIs
Data are expressed as means ± SE. Statistical analyses of cytokine/
chemokine concentrations were performed using the Kruskal–
Wallis and Mann–Whitney U methods. Subsequent post hoc analysis 
was conducted using the Bonferroni-adjusted α method. All statis-
tical analyses were performed using SPSS version 12.0 (SPSS Inc., 
Chicago, IL, USA). Values of p < 0.05 were considered significant.
results
experIMental condItIons
To confirm the infection of human fetal lung fibroblasts with PIV, 
morphological changes in the cells were examined by light micro-
scopy after 6, 24, and 48 h. No changes were observed 6 h after 
PIV infection, whereas the cells clearly showed CPE after 48 h of 
PIV infection (data not shown). We confirmed that there were no 
significant differences in the amounts of cytokines released between 
the UV-treated virus treatment, medium with 0.1% DMSO, and 
medium alone (without the addition of viruses) (data not shown). 
Of the 27 cytokines examined, significantly higher amounts of 18 
IκB kinase, p38 MAPK, and Akt are major signaling molecules 
thought to play a pivotal role in most types of cytokine production 
in various cells (Hiscott et al., 2001; Adcock et al., 2006). Single 
strand RNA such as viral RNA binds and activates helicase, which 
further activates IκB kinase pathways, resulting in the production 
of certain types of cytokine (Lee and Lau, 2007). In addition, it is 
well known that phosphorylation of p38 MAPK is associated with 
the production of cytokines in many types of cells (Suzuki et al., 
1999; Wong et al., 2005). Thus, these signaling molecules may be 
associated with the production of cytokines in virus-infected cells, 
although the details are not as yet known.
 Human lung fibroblasts are reported to be susceptible to vari-
ous respiratory viruses such as PIV and RV (Bousse et al., 2006; 
Jang et al., 2009). In addition, lung fibroblasts may be associated 
with remodeling involved in fibrosis in the small airways (Puxeddu 
et al., 2006). In asthmatics, viral infections are more likely to result 
in lower respiratory tract infection (Gern, 2009), and moreover, 
these infections are not restricted to the respiratory epithelium, 
but can spread to the structural cells such as smooth muscle cells 
and fibroblasts (Holgate et al., 2004b). From these background, in 
the present study we chose human fetal lung fibroblasts to examine 
the cytokine milieu of the asthmatic airway under chronic viral 
infection. We hypothesized that PIV infection might induce virus-
induced asthma-related cytokine production in fetal lung fibrob-
lasts. To explore this possibility, we profiled cytokines released from 
PIV-infected fetal lung fibroblasts and examined the role of the 
signaling pathways (IκB kinase, p38 MAPK, and Akt).
MaterIals and Methods
cells and cell culture
Human fetal lung fibroblasts (MRC-5 cells) were purchased from 
the American Type Culture Collection (ATCC, Manassas, VA, USA). 
Cells were grown in 75-cm2 tissue culture flasks and maintained 
in  Eagle’s  minimum  essential  medium  (MEM;  Invitrogen  Life 
Technologies, CA, USA) containing 10% fetal bovine serum (FBS), 
l-glutamine (0.6 mg/ml), and 0.35% NaHCO3 at 36°C in a humidi-
fied atmosphere containing 5% CO2 (de Oña et al., 1995).
VIral propagatIon and MeasureMent of VIral tIters
Human PIV type 3 (C 243 strain) were obtained from American 
Tissue Culture Corrections (Rockville, MD, USA) and propagated in 
Vero E6 cells. When the PIV-infected Vero E6 cells showed cytopathic 
effects (CPE), they were centrifuged at 4200 × g for 30 min at 4°C to 
remove debris. To purify the viruses, the supernatants were layered 
over 50% sucrose in PBS, then centrifuged at 65,000 × g for 2 h at 
4°C as previously described (Ueba, 1978). Aliquots of the viruses 
were stored at −80°C until required.
MeasureMent of cytokIne concentratIons
We inoculated 0 (no virus) or 1.0 MOI of each virus suspension 
(100 μl) in Opti-MEM I to the human fetal lung fibroblasts grown in 
96-well microplates. Concentrations of cytokines, chemokines, and 
growth factors in the culture supernatants from each experimental 
system (virus-infected, UV-inactivated virus, inhibitor-added, and 
no virus) were obtained at 24 h. To remove the effect of intracellular 
cytokines/chemokines, we centrifuged the microplates at 1660 × g 
for 10 min before carefully harvesting the supernatants.www.frontiersin.org  November 2010  | Volume 1  | Article 124  |  3
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Figure 1 | Proinflammatory cytokine, Th1 cytokine, Th2 cytokine, growth 
factor, chemokine, and tissue remodeling-related cytokine levels in culture 
supernatants from PiV-infected human fetal lung fibroblasts. All assays 
were performed in duplicate in five independent experiments. “Control” 
indicates no addition of virus to the fibroblasts. BMS-345541 and SB203580 
indicate addition of each inhibitor within 60 min of PIV infection. Vertical bars 
represent mean ± SE. *p < 0.05 when compared with the cytokine levels 
induced by infection with PIV.
cytokines were released after addition of 1.0 MOI of PIV compared 
with no addition of viruses (data not shown). Cytokine release by 
viruses was MOI-dependent (data not shown).
categorIzatIon of cytokInes released by pIV-Infected huMan 
fetal lung fIbroblasts
Next, we compared the cytokine levels induced between control 
and PIV-infected fibroblasts. The amounts of 18 cytokines induced 
by PIV infection were significantly higher, at least at one time 
point, than those of control cells. The 18 cytokines were catego-
rized into nine groups (Barnes, 2008): proinflammatory cytokines 
(Figures  1A–C),  anti-inflammatory  cytokines,  (Figure  1D), 
Th1  cytokines  (Figures  1E,F),  Th2  cytokines  (Figures  1G–I), 
granulopoiesis-inducing  cytokines  (Figures  1J,K),  neutrophil 
recruitment-inducing  chemokines  (Figures  1L,M),  eosinophil 
recruitment-inducing  chemokines  (Figures  1N,O),  and  tissue 
remodeling-related cytokines (Figures 1P,Q).
coMparIson of proInflaMMatory and antI-InflaMMatory 
cytokInes released by pIV-Infected huMan fetal lung 
fIbroblasts
As shown in Figures 1A–C, proinflammatory cytokine (IL-1β, IL-6 
and TNF-α levels at 24 h after infection with PIV were significantly 
higher than levels of control cells. Similarly, the level of IL-1ra (anti-
inflammatory cytokine) was significantly higher from PIV-infected 
cells than from the control cells (Figure 1D).Frontiers in Microbiology  |  Virology    November 2010  | Volume 1  | Article 124  |  4
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MRC-5 cells compared with the control (Figures 2A,B). However, no 
enhancement of Akt phosphorylation was found in the virus-infected 
cells (Figure 2C). Thus, to define the role of the IκB kinase and p38 
MAPK pathways in viral induction of cytokines and chemokines, 
we used their specific inhibitors. As a result, in MRC-5 cells, inhibi-
tion of the NF-κB pathway with BMS-345541 (10 μM) significantly 
inhibited PIV-induced cytokines, namely, IL-1β, 1ra, 2, 4, 5, 6, 8, 10, 
IFN-γ, TNF-α, G-CSF, GM-CSF, IP-10, eotaxin, RANTES, PDGF-bb, 
and VEGF (Figure 1). Similarly, treatment of the p38 MAPK pathway 
with SB203580 (10 μM) also significantly inhibited the release of 
these cytokines (Figure 1). The results suggested that both IκB kinase 
and p38 MAPK phosphorylation was associated with the production 
and release of various cytokines in the virus-infected cells.
Discussion
We profiled a number of cytokines from PIV-infected fetal lung 
fibroblasts. Compared with control (no virus) cells, a significant 
amount of various cytokines were shown to be released, namely, 
IL-1β, IL-6, TNF-α, IL-1ra, IFN-γ, IL-2, IL-4, IL-5, IL-10, G-CSF, 
GM-CSF, IL-8, IP-10, eotaxin, RANTES, PDGF-bb, and VEGF. In 
addition, we found that most aberrantly released cytokines were 
associated with phosphorylation of IκB kinase and p38 MAPK. 
Infection by PIV may induce large-scale production of various 
cytokines in the airway. Although PIV failed to induce IL-12 and 
IL-17 production, these results indicate that PIV induces a Th2 
cytokine milieu as well as eosinophil and neutrophil recruitment 
to fibroblasts. As a result, Th2 immunity may be augmented, which 
is likely to be an important mechanism in the pathophysiology of 
PIV-induced asthma (virus-induced asthma).
comparison of Th1, Th17, anD Th2 cyTokines releaseD by 
piV-infecTeD human feTal lung fibroblasTs
To clarify the differences in Th1, Th17, and Th2 cytokine profiles 
between PIV-infected human fetal lung fibroblasts and control cells, 
we compared levels of IFN-γ, IL-2, IL-12, IL-17, IL-4, IL-5, IL-10, and 
IL-13. We found that small but significant amounts of IFN-γ and IL-2 
were produced by PIV-infected fibroblasts compared with control 
fibroblasts (Figures 1E,F), but there was no significant difference in 
IL-12 levels (data not shown). In addition, PIV infection did not result 
in any significant difference in amounts of IL-17 from fibroblasts 
compared with the control (data not shown). PIV infection did result 
in significantly higher production of IL-4, IL-5, and IL-10 compared 
with the control (Figures 1G–I), but not IL-13 (data not shown).
comparison of growTh facTors anD chemokines releaseD by 
piV-infecTeD human feTal lung fibroblasTs
G-CSF and GM-CSF levels induced by PIV infection were signifi-
cantly higher than those induced by the control (Figures 1J,K). 
Similarly, IL-8, IP-10, eotaxin, and RANTES levels were significantly 
higher in supernatants from PIV-infected fibroblasts than control 
fibroblasts (Figures 1L–O). Regarding cytokines related to tissue 
remodeling, the same tendency was observed; PDGF-bb and VEGF 
levels were significantly higher in supernatants from PIV-infected 
fibroblasts compared with control fibroblasts (Figures 1P,Q).
phosphorylaTion of iκb kinase, p38 mapk, anD akt
To examine possible signal molecules, we investigated the phospho-
rylation of IκB kinase, p38 MAPK, and Akt. PIV infection dramati-
cally induced the phosphorylation of IκB kinase and p38 MAPK in 
Ικβ−α p38 MAPK
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bronchoalveolar cells (Krug et al., 1996). Recently, Magnan et al. 
(2000) demonstrated increased IFN-γ-producing CD8+ T cells in 
asthmatic airways, and the levels of IFN-γ correlated with asthma 
severity, bronchial hyper-responsiveness, and blood eosinophilia 
(Ishihara et al., 1997). IFN-γ has been reported to be associated 
with severe and chronic asthma. In the present study, PIV-infected 
human lung fibroblasts produced and released IFN-γ, which might 
be associated with severity of asthma.
Cytokine production-related signaling pathways related to viral 
infections have been reported (Santoro et al., 2003; Kohlmeier et al., 
2009; Zaheer et al., 2009). For example, Lee et al. suggested that 
single strand viral RNA of influenza virus binds to the host cellu-
lar helicase resulting in activation of signaling pathways including 
IκB kinase (Lee and Lau, 2007). In addition, viral single strand or 
double strand RNA/MKK3/6 complex can also activate p38 MAPK 
(Stephan, 2007). Finally, activation of these pathways may lead 
to the production and release of cytokines in virus-infected cells 
as an antiviral response (Stephan, 2007). In the present study, at 
24 h after PIV infection, phosphorylation of IκB kinase and p38 
MAPK and the release of cytokines were significantly increased in 
lung fibroblasts. Furthermore, inhibition of phosphorylation of 
these kinases by specific inhibitors significantly eliminated release 
of cytokines (Figure 2). At 24 h after infection, PIV genomes (also 
single strand RNA) may be significantly propagated (De et al., 
1990). A possible reason for this is that the increase in phospho-
rylation of IκB kinase and p38 MAPK after PIV infection might 
be associated with propagated PIV genomes in the cells, although 
we did not observe an increase in the PIV genome/helicase or PIV 
genome MKK3/6 complex.
Fibroblasts have the potential to play a critical role in remodeling 
of and changes in the airway matrix (Holgate et al., 2004a). In this 
study, we found that PIV infection-induced significantly higher 
production of Th1 and Th2 cytokines from fibroblasts compared 
to control cells. PIV might promote release of not only inflamma-
tory cytokines but also allergy-related cytokines in virus-infected 
MRC-5 cells. From the present results and previous our results 
suggest that aberrant release/production of various cytokines (i.e., 
cytokine storm) due to PIV or RSV infection is also associated 
with severe respiratory infection such as pneumonia (Ishioka et al., 
2010). In addition, we showed that this cytokine production may 
be closely linked to phosphorylation of signal molecules such as 
IκB kinase and p38 MAPK. Recurrent RSV infection may damage 
the lower respiratory airways and induce remodeling. Finally, our 
findings suggest that PIV infection-induced aberrant phosphor-
ylation of IκB kinase and p38 MAPK in lung fibroblasts might 
mediate hypersensitive Th1- and Th2-type responses in subjects 
with asthma, which is likely an important mechanism in virus-
induced asthma.
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It is suggested that maximal MAP kinase phosphorylation and 
activity is seen within 60 min after stimulation. In this study, the 
phosphorylation of IκB kinase and p38 MAP kinase was examined 
at 24 h after PIV infection. Thus, it is possible that cytokines pro-
duced by PIV-infected MRC-5 cells might be responsible for the 
induction of MAP kinase phosphorylation, since various cytokines 
produced after PIV infection have been shown to induce IκB kinase 
and MAP kinase phosphorylation.
We speculate that the effects of PIV on normal fibroblasts can be 
extrapolated to corresponding cells in asthmatic airways. Previous 
studies have shown that increased viral replication and impaired 
IFN response to viral infection occurs in primary epithelial cells 
and peripheral blood cells from asthmatics compared with nor-
mal subjects (Wark et al., 2005; Contoli et al., 2006; Gehlhar et al., 
2006). The increase in virus infection-induced inflammation is a 
probable explanation for these observations. Asthmatics may also 
be more susceptible to infection (Holgate, 2007). Furthermore, 
it has also been suggested that infants who are born with poor 
antiviral responses and/or airway hyper-responsiveness are prone 
to repetitive severe illnesses (Gehlhar et al., 2006), and these same 
abnormalities may increase the risk of recurrent wheezing and 
possibly asthma. Therefore, fibroblasts from those who develop 
asthma in earlier childhood might possess a defective IFN response 
to these respiratory viruses. Such partially defective innate immune 
responses may result in augmented Th2 immunity in asthmatic 
patients as well as increased and prolonged airway inflammation 
(Barrett and Austen, 2009).
A direct causative role for these respiratory viruses in the devel-
opment of asthma has not been proven yet. Lemanske et al. (2005) 
suggested at least two potential mechanisms for the development 
of recurrent wheezing in early childhood. First, healthy infants 
who undergo repetitive severe viral respiratory infections could 
develop recurrent wheezing because of lung damage and/or airway 
remodeling. Second, as mentioned above, infants who are born with 
weak antiviral responses and/or airway hyper-responsiveness are 
prone to repetitive severe illnesses, which may increase the risk of 
recurrent wheezing and possibly asthma. A recent study suggests 
that RSV-induced wheezing is an indicator of genetic predisposition 
to asthma, but is not associated with allergic sensitization, irre-
spective of the family history of asthma (Singh et al., 2007). In the 
present study, PIV-infected human lung fibroblasts produced and 
released tissue remodeling-related cytokines (PDGF and VEGF) 
and proinflammatory cytokines (IL-1β, IL-6, and TNF-α) com-
pared with the control. Using animal models, it was also recently 
suggested that endotracheal inoculation of PIV induces biological 
and histological changes reminiscent of asthma (Pelaia et al., 2006). 
In particular, PIV infection elicits an airway influx of inflammatory 
cells, bronchial hyper-responsiveness, epithelial damage, and bron-
chiolar fibrosis (Pelaia et al., 2006). These findings suggest that the 
recurrence of PIV infections in patients with asthma may contribute 
to prolonged airway inflammation and airway structural changes 
typical of the disease (Pelaia et al., 2006). Moreover, our results 
suggest that PIV-induced tissue remodeling-related cytokines and 
proinflammatory cytokines from human fibroblasts may be asso-
ciated with respiratory remodeling and prolonged airway inflam-
mation after infection. Human asthma subjects have exhibited 
significant increases in IFN-γ, in the supernatants of cultured Frontiers in Microbiology  |  Virology    November 2010  | Volume 1  | Article 124  |  6
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